Some error occured while loading the Quick View. Please close the Quick View and try reloading the page.
The goal of this comprehensive text is to enable ophthalmologists and rheumatologists to differentiate scleral disorders and implement timely treatment plans based on current best practice and available evidence. Extensive updates to text reflect the advances that have occurred in investigation and treatment of scleral disease since the 2nd edition was written between 1998 and 2003. Numerous new and replacement images of the highest quality, particularly (in chapter 5) of Anterior Segment OCT which is being adapted to investigate scleral disease with stunning results. 1000+ new references to relevant key review and research papers.
Peter G Watson MA MB BChir FRCS FRCOphth DO
Hon Consultant Ophthalmic Surgeon, Addenbrooke’s Hospital, Cambridge, Moorfields Eye Hospital, London
Brian L Hazleman MA FRCP
Hon Consultant Rheumatologist, Addenbrooke’s Hospital, Cambridge
Peter M McCluskey MBBS MD FRANZCO FRACS
Director, Save Sight Institute, and Professor of Ophthalmology, University of Sydney, Australia
Carlos E Pavésio MD FRCOphth
Consultant Ophthalmologist, Moorfields Eye Hospital, London
Chapter 1 – Historical introduction
Chapter 2 – Anatomical, physiological and comparative aspects
Chapter 3 – Clinical assessment of the eye and the joints in scleral disease
Chapter 4 – Clinical presentation of scleritis and episcleritis
Chapter 5 – Investigation of scleral disease
Chapter 6 – Ocular complications of scleritis
Chapter 7 – Pathology and pathogenesis of scleritis and sclerokeratitis
Chapter 8 – Scleritis in relation to connective tissue disorders
Chapter 9 – Scleral disease in relation to other systemic disorders
Chapter 10 – The sclera in myopia
Chapter 11 – Other affections of the sclera
Chapter 12 – Treatment of scleral and associated inflammatory disease